The Toronto-Dominion Bank
TD
Shopify Inc
SHOP
Air Canada
AC
4
GoldMining Inc
GOLD
5
Palantir Technologies Inc
PLTR
CA Stock MarketDetailed Quotes
MDNA Medicenna Therapeutics Corp
- 1.220
- +0.060+5.17%
15min DelayMarket Closed May 1 16:00 ET
95.42MMarket Cap-3.30P/E (TTM)
1.230High1.160Low16.61KVolume1.160Open1.160Pre Close19.91KTurnover2.98052wk High0.03%Turnover Ratio78.22MShares0.85052wk Low-0.37EPS TTM62.11MFloat Cap7.250Historical HighLossP/E (Static)50.91MShs Float0.215Historical Low-0.37EPS LYR6.03%Amplitude--Dividend TTM5.47P/B1Lot Size--Div YieldTTM
Medicenna Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 7.18%5.12M | 1.66%5.53M | -9.40%4.04M | 14.54%18.67M | 34.67%4M | -2.93%4.78M | 33.23%5.44M | 2.98%4.46M | -27.46%16.3M | -4.99%2.97M |
| Selling and administrative expenses | -7.12%1.66M | -22.20%1.79M | -23.88%1.25M | 12.51%7.87M | 54.41%2.14M | -9.63%1.78M | 34.07%2.3M | -14.23%1.65M | -9.40%6.99M | -28.25%1.38M |
| -General and administrative expense | -7.12%1.66M | -22.20%1.79M | -23.88%1.25M | 12.51%7.87M | 54.41%2.14M | -9.63%1.78M | 34.07%2.3M | -14.23%1.65M | -9.40%6.99M | -28.25%1.38M |
| Research and development costs | 15.08%3.44M | 18.89%3.73M | -1.07%2.78M | 16.08%10.8M | 17.47%1.86M | 1.56%2.99M | 32.68%3.13M | 16.63%2.81M | -36.78%9.3M | 33.17%1.59M |
| Depreciation amortization depletion | 950.00%21K | 900.00%10K | 400.00%5K | 0.00%5K | 0.00%1K | 0.00%2K | -50.00%1K | --1K | -86.49%5K | -85.71%1K |
| -Depreciation and amortization | 950.00%21K | 900.00%10K | 400.00%5K | 0.00%5K | 0.00%1K | 0.00%2K | -50.00%1K | --1K | -86.49%5K | -85.71%1K |
| Operating profit | -7.18%-5.12M | -1.66%-5.53M | 9.40%-4.04M | -14.54%-18.67M | -34.67%-4M | 2.93%-4.78M | -33.23%-5.44M | -2.98%-4.46M | 27.46%-16.3M | 4.99%-2.97M |
| Net non-operating interest income (expenses) | 34.04%378K | 10.53%378K | -4.62%330K | 31.07%1.2M | -40.31%228K | -17.06%282K | 111.11%342K | 1,053.33%346K | 1,224.64%914K | 4,144.44%382K |
| Non-operating interest income | 34.04%378K | 10.53%378K | -4.62%330K | 31.07%1.2M | -40.31%228K | -17.06%282K | 111.11%342K | 1,053.33%346K | 1,224.64%914K | 4,144.44%382K |
| Other net income (expenses) | 6.85%-449K | -28.21%985K | -94.16%73K | -249.60%-7.99M | -699.61%-10.13M | -114.01%-482K | -54.61%1.37M | 762.76%1.25M | 3,187.28%5.34M | -1,339.77%-1.27M |
| Gain on sale of security | 6.85%-449K | -28.21%985K | -94.16%73K | -249.60%-7.99M | -699.61%-10.13M | -114.01%-482K | -54.61%1.37M | 762.76%1.25M | 3,187.28%5.34M | -1,339.77%-1.27M |
| Income before tax | -4.30%-5.19M | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -4.30%-5.19M | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M |
| Net income continuous operations | -4.30%-5.19M | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -4.30%-5.19M | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -4.30%-5.19M | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M |
| Diluted earnings per share | 0.00%-0.07 | 0.00%-0.05 | -25.00%-0.05 | -131.25%-0.37 | -233.33%-0.2 | -250.00%-0.07 | -400.00%-0.05 | 42.86%-0.04 | 61.90%-0.16 | 0.00%-0.06 |
| Basic earnings per share | 0.00%-0.07 | 0.00%-0.05 | -25.00%-0.05 | -131.25%-0.37 | -233.33%-0.2 | -250.00%-0.07 | -400.00%-0.05 | 42.86%-0.04 | 61.90%-0.16 | 0.00%-0.06 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.